The Journal of Rheumatology: 32 (10)

October 01, 2005; Volume 32,Issue 10

You have access
Preventing deaths from methotrexate overdose.
Edward Etchells

The Journal of Rheumatology October 1 2005, 32 (10) 1853-1855;
You have access
Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
John M Davis 3rd, Hilal Maradit-Kremers and Sherine E Gabriel

The Journal of Rheumatology October 1 2005, 32 (10) 1856-1862;
You have access
Steroids for rheumatoid arthritis: the honeymoon revisited (once again).
Liron Caplan, Anthony S Russell and Frederick Wolfe

The Journal of Rheumatology October 1 2005, 32 (10) 1863-1865;
You have access
Malignancy and rheumatic disease--a real association?
Sharon Chambers and David Isenberg

The Journal of Rheumatology October 1 2005, 32 (10) 1866-1867;
You have access
Bone mineral content versus bone density in a population with osteoarthritis: a new twist to the controversy?
M Heather McDonald Blumer

The Journal of Rheumatology October 1 2005, 32 (10) 1868-1869;
You have access
ADAM proteins as therapeutic targets in loosening of total hip replacement implants?
Silvia Naus and Jörg Walter Bartsch

The Journal of Rheumatology October 1 2005, 32 (10) 1870-1872;
You have access
Race, scleroderma, and survival: why is there a difference?
Maureen D Mayes

The Journal of Rheumatology October 1 2005, 32 (10) 1873-1874;
You have access
Household income and earnings losses among 6,396 persons with rheumatoid arthritis.
Frederick Wolfe, Kaleb Michaud, Hyon K Choi and Rhys Williams

The Journal of Rheumatology October 1 2005, 32 (10) 1875-1883;
You have access
Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.
Janet Cuttner, Harry Spiera, Kevin Troy and Sylvan Wallenstein

The Journal of Rheumatology October 1 2005, 32 (10) 1884-1887;
You have access
Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis.
Paul J Nietert, Richard M Silver, Holly C Mitchell, Stephanie R Shaftman and Barbara C Tilley

The Journal of Rheumatology October 1 2005, 32 (10) 1888-1892;
You have access
Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
Florenzo Iannone, Marco Matucci-Cerinic, Paola Chiara Francesca Falappone, Serena Guiducci, Marina Cinelli, Oliver Distler and Giovanni Lapadula

The Journal of Rheumatology October 1 2005, 32 (10) 1893-1898;
You have access
The Cochrane review of physiotherapy interventions for ankylosing spondylitis.
Hanne Dagfinrud, Tore K Kvien and Kåre B Hagen

The Journal of Rheumatology October 1 2005, 32 (10) 1899-1906;
You have access
Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea.
Tae-Hwan Kim, Millicent A Stone, Proton Rahman, Dae-Hyun Yoo, Yong-Wook Park, Ursula Payne, Dave Hallett and Robert D Inman

The Journal of Rheumatology October 1 2005, 32 (10) 1907-1910;
You have access
Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
Walter P Maksymowych, A Robin Poole, Lori Hiebert, Alison Webb, Mirela Ionescu, Tatiana Lobanok, Lindsay King and John C Davis Jr

The Journal of Rheumatology October 1 2005, 32 (10) 1911-1917;
You have access
Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway.
Tor Magne Madland, Ellen M Apalset, Arild E Johannessen, Berthe Rossebö and Johan G Brun

The Journal of Rheumatology October 1 2005, 32 (10) 1918-1922;
You have access
Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.
José Alvarez-Nemegyei, Julio Cesar Cen-Pisté, Martha Medina-Escobedo and Salha Villanueva-Jorge

The Journal of Rheumatology October 1 2005, 32 (10) 1923-1927;
You have access
Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial.
David Neustadt, Jacques Caldwell, Mary Bell, John Wade and Joseph Gimbel

The Journal of Rheumatology October 1 2005, 32 (10) 1928-1936;
You have access
The genetic contribution and relevance of knee cartilage defects: case-control and sib-pair studies.
Changhai Ding, Flavia Cicuttini, Fiona Scott, James Stankovich, Helen Cooley and Graeme Jones

The Journal of Rheumatology October 1 2005, 32 (10) 1937-1942;
You have access
Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.
Guofeng Ma, Mari Ainola, Mikko Liljeström, Seppo Santavirta, Praseet Poduval, Desheng Zhao, Tong Chen and Yrjö T Konttinen

The Journal of Rheumatology October 1 2005, 32 (10) 1943-1950;
You have access
Increased bone mineral content but not bone mineral density in the hip in surgically treated knee and hip osteoarthritis.
Lorenzo Sandini, Jari P A Arokoski, Jukka S Jurvelin and Heikki Kröger

The Journal of Rheumatology October 1 2005, 32 (10) 1951-1957;
You have access
Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
Rina Andriamanalijaona, Madeleine Kypriotou, Catherine Baugé, Emmanuelle Renard, Florence Legendre, Maha Raoudi, Karim Boumediene, Hugues Gatto, Patricia Monginoux and Jean-Pierre Pujol

The Journal of Rheumatology October 1 2005, 32 (10) 1958-1967;
You have access
Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
Mark P Ettinger, Dieter Felsenberg, Steven T Harris, Richard Wasnich, Arne Skag, Valerie Hiltbrunner, Katie Wilson, Ralph C Schimmer and Paul D Miller

The Journal of Rheumatology October 1 2005, 32 (10) 1968-1974;
You have access
Efficacy of milnacipran in patients with fibromyalgia.
R Michael Gendreau, Michael D Thorn, Judy F Gendreau, Jay D Kranzler, Saulo Ribeiro, Richard H Gracely, David A Williams, Philip J Mease, Samuel A McLean and Daniel J Clauw

The Journal of Rheumatology October 1 2005, 32 (10) 1975-1985;
You have access
Eye findings in patients with juvenile dermatomyositis.
Jonathan D Akikusa, Dhenuka K Tennankore, Alex V Levin and Brian M Feldman

The Journal of Rheumatology October 1 2005, 32 (10) 1986-1991;
You have access
Longitudinal analysis of a pediatric rheumatology clinic population.
Alan M Rosenberg

The Journal of Rheumatology October 1 2005, 32 (10) 1992-2001;
You have access
Poststreptococcal reactive arthritis with thoracic spine involvement in an adult.
Alexandra Alexopoulou, Spyros P Dourakis, Nikolaos D Stamoulis, Dimitrios Vassilopoulos and Athanasios J Archimandritis

The Journal of Rheumatology October 1 2005, 32 (10) 2002-2005;
You have access
Synovial sarcoma of the foot mimicking acute gouty arthritis.
Ying Du, Sally Pullman-Mooar and H Ralph Schumacher

The Journal of Rheumatology October 1 2005, 32 (10) 2006-2008;
You have access
Deaths following methotrexate overdoses by medical staff.
Inga Sinicina, Barbara Mayr, Gita Mall and Wolfgang Keil

The Journal of Rheumatology October 1 2005, 32 (10) 2009-2011;
You have access
Minimal disease activity for rheumatoid arthritis: a preliminary definition.
George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell

The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;
You have access
Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues.
Florence Tubach, George A Wells, Philippe Ravaud and Maxime Dougados

The Journal of Rheumatology October 1 2005, 32 (10) 2025-2029;
You have access
Challenges and progress in adverse event ascertainment and reporting in clinical trials.
Marissa N D Lassere, Kent R Johnson, Thasia G Woodworth, Daniel E Furst, James F Fries, John R Kirwan, Peter S Tugwell, Richard O Day and Peter M Brooks

The Journal of Rheumatology October 1 2005, 32 (10) 2030-2032;
You have access
Generic patient self-report and investigator report instruments of therapeutic safety and tolerability.
Marissa N D Lassere, Kent R Johnson, Susanne Van Santen, Kerri Carlton, Joy Rappo, Rachel Michael, John R Kirwan and John P Edmonds

The Journal of Rheumatology October 1 2005, 32 (10) 2033-2036;
You have access
Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks

The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;
You have access
Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
Désirée M F M van der Heijde, Robert B M Landewé, Kay-Geert A Hermann, Anne-Grethe Jurik, Walter P Maksymowych, Martin Rudwaleit, Philip J O'Connor and Jürgen Braun

The Journal of Rheumatology October 1 2005, 32 (10) 2042-2047;
You have access
Selection of a method for scoring radiographs for ankylosing spondylitis clinical trials, by the Assessment in Ankylosing Spondylitis Working Group and OMERACT.
Désirée van der Heijde and Robert Landewé

The Journal of Rheumatology October 1 2005, 32 (10) 2048-2049;
You have access
Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
Robert B M LandewÉ, Kay-Geert A Hermann, DÉsirÉÉe M F M van der Heijde, Xenophon Baraliakos, Anne-Grethe Jurik, Robert G Lambert, Mikkel Østergaard, Martin Rudwaleit, David C Salonen and JÜrgen Braun

The Journal of Rheumatology October 1 2005, 32 (10) 2050-2055;
You have access
Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?
Kay-Geert A Hermann, Robert B M Landewé, Jürgen Braun and Désirée M F M van der Heijde

The Journal of Rheumatology October 1 2005, 32 (10) 2056-2060;
You have access
Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
Antonio Juan, Bartolome Ribas, Cristina Nadal and Imnaculada Ros

The Journal of Rheumatology October 1 2005, 32 (10) 2061;
You have access
CTLA-4 -1661A/G and -1772T/C dimorphisms in Japanese patients with systemic lupus erythematosus.
Fujio Takeuchi, Shoji Kuwata and Masaki Mori

The Journal of Rheumatology October 1 2005, 32 (10) 2062;

Main menu

User menu

Search

Table of Contents

In this issue

Content

Resources

Subscribers

More